Royal Bank of Canada
RGC icon

Royal Bank of Canada’s Regencell Bioscience RGC Stock Holding History

Royal Bank of Canada’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Buy
+69
New +$1.95K ﹤0.01% 6750
2025
Q2 		– Sell
-36,024
Closed -$30K – 7295
2025
Q1 		$30K Buy
+36,024
New +$9.95K ﹤0.01% 5778

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Royal Bank of Canada's RGC Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Regencell Bioscience (RGC) in Q1 2026: 69 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #6750 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in RGC as recently as Q1 2025.

Royal Bank of Canada first reported a position in RGC in Q1 2025 and has held it in 2 quarters since. The position peaked at $30K in Q1 2025. 31 funds tracked by Wall St. Rank hold RGC as of Q1 2026.

  • Royal Bank of Canada held 69 shares of Regencell Bioscience worth $2K as of Q1 2026.
  • Regencell Bioscience was a new Royal Bank of Canada position in Q1 2026.
  • Regencell Bioscience made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6750 holding.
  • Royal Bank of Canada first reported a position in Regencell Bioscience in Q1 2025 and has held it in 2 quarters since.
  • Royal Bank of Canada's Regencell Bioscience position peaked at $30K in Q1 2025.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.